Amlodipine besylate
- Product NDC
- 71335-0833
- 11-digit product format
- 713350833
- Labeler code
- 71335
- Product ID
- 71335-0833_c9d18f34-5d9f-4f67-afbd-d28b28cbe15e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Amlodipine besylate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA077955
- Marketing category
- ANDA
- Marketing start
- 2007-11-02
- Substance
- AMLODIPINE BESYLATE
- Active strength
- 2.5 mg/1
- Pharmacologic classes
- Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Amlodipine besylate
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| AMLODIPINE BESYLATE | 2.5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 864V2Q084H |
| Rxcui | 308136 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 71335-0833-1 | 2024-05-15 | C162847 | 48780-1 | 1030e365-28bb-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use AMLODIPINE BESYLATE TABLETS safely and effectively. See full prescribing information for AMLODIPINE BESYLATE TABLETS. AMLODIPINE BESYLATE tablets, for oral administration Initial U.S. Approval: 1992 |
| 71335-0833-2 | 2024-05-15 | C162847 | 48780-1 | 1030e365-28bb-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use AMLODIPINE BESYLATE TABLETS safely and effectively. See full prescribing information for AMLODIPINE BESYLATE TABLETS. AMLODIPINE BESYLATE tablets, for oral administration Initial U.S. Approval: 1992 |
| 71335-0833-3 | 2024-05-15 | C162847 | 48780-1 | 1030e365-28bb-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use AMLODIPINE BESYLATE TABLETS safely and effectively. See full prescribing information for AMLODIPINE BESYLATE TABLETS. AMLODIPINE BESYLATE tablets, for oral administration Initial U.S. Approval: 1992 |
| 71335-0833-4 | 2024-05-15 | C162847 | 48780-1 | 1030e365-28bb-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use AMLODIPINE BESYLATE TABLETS safely and effectively. See full prescribing information for AMLODIPINE BESYLATE TABLETS. AMLODIPINE BESYLATE tablets, for oral administration Initial U.S. Approval: 1992 |
| 71335-0833-5 | 2024-05-15 | C162847 | 48780-1 | 1030e365-28bb-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use AMLODIPINE BESYLATE TABLETS safely and effectively. See full prescribing information for AMLODIPINE BESYLATE TABLETS. AMLODIPINE BESYLATE tablets, for oral administration Initial U.S. Approval: 1992 |
| 71335-0833-6 | 2024-05-15 | C162847 | 48780-1 | 1030e365-28bb-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use AMLODIPINE BESYLATE TABLETS safely and effectively. See full prescribing information for AMLODIPINE BESYLATE TABLETS. AMLODIPINE BESYLATE tablets, for oral administration Initial U.S. Approval: 1992 |
| 71335-0833-1 | 2024-01-30 | C162847 | 48780-1 | 1030e365-28bb-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use AMLODIPINE BESYLATE TABLETS safely and effectively. See full prescribing information for AMLODIPINE BESYLATE TABLETS. AMLODIPINE BESYLATE tablets, for oral administration Initial U.S. Approval: 1992 |
| 71335-0833-2 | 2024-01-30 | C162847 | 48780-1 | 1030e365-28bb-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use AMLODIPINE BESYLATE TABLETS safely and effectively. See full prescribing information for AMLODIPINE BESYLATE TABLETS. AMLODIPINE BESYLATE tablets, for oral administration Initial U.S. Approval: 1992 |
| 71335-0833-3 | 2024-01-30 | C162847 | 48780-1 | 1030e365-28bb-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use AMLODIPINE BESYLATE TABLETS safely and effectively. See full prescribing information for AMLODIPINE BESYLATE TABLETS. AMLODIPINE BESYLATE tablets, for oral administration Initial U.S. Approval: 1992 |
| 71335-0833-4 | 2024-01-30 | C162847 | 48780-1 | 1030e365-28bb-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use AMLODIPINE BESYLATE TABLETS safely and effectively. See full prescribing information for AMLODIPINE BESYLATE TABLETS. AMLODIPINE BESYLATE tablets, for oral administration Initial U.S. Approval: 1992 |
| 71335-0833-5 | 2024-01-30 | C162847 | 48780-1 | 1030e365-28bb-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use AMLODIPINE BESYLATE TABLETS safely and effectively. See full prescribing information for AMLODIPINE BESYLATE TABLETS. AMLODIPINE BESYLATE tablets, for oral administration Initial U.S. Approval: 1992 |
| 71335-0833-6 | 2024-01-30 | C162847 | 48780-1 | 1030e365-28bb-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use AMLODIPINE BESYLATE TABLETS safely and effectively. See full prescribing information for AMLODIPINE BESYLATE TABLETS. AMLODIPINE BESYLATE tablets, for oral administration Initial U.S. Approval: 1992 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71335-0833-1 | Amlodipine besylate | 30 in 1 BOTTLE | TABLET | 30 | | 7 |
| 71335-0833-2 | Amlodipine besylate | 90 in 1 BOTTLE | TABLET | 90 | | 7 |
| 71335-0833-3 | Amlodipine besylate | 120 in 1 BOTTLE | TABLET | 120 | | 7 |
| 71335-0833-4 | Amlodipine besylate | 60 in 1 BOTTLE | TABLET | 60 | | 7 |
| 71335-0833-5 | Amlodipine besylate | 500 in 1 BOTTLE | TABLET | 500 | | 7 |
| 71335-0833-6 | Amlodipine besylate | 10 in 1 BOTTLE | TABLET | 10 | | 7 |
| 71335-0833-7 | Amlodipine besylate | 100 in 1 BOTTLE | TABLET | 100 | | 7 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71335-0833 | AMLODIPINE BESYLATE TABLET [BRYANT RANCH PREPACK] | 7 | Current NDC, Legacy NDC, 7 package rows | 20240517_c3742b31-11f6-4c11-98e3-75916a1982d4.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-0833-1 | 71335083301 | 30 TABLET in 1 BOTTLE (71335-0833-1) | 30 tablet | 2018-10-10 | 0000-00-00 | No | No | Current |
| 71335-0833-2 | 71335083302 | 90 TABLET in 1 BOTTLE (71335-0833-2) | 90 tablet | 2018-05-16 | 0000-00-00 | No | No | Current |
| 71335-0833-3 | 71335083303 | 120 TABLET in 1 BOTTLE (71335-0833-3) | 120 tablet | 2021-12-27 | 0000-00-00 | No | No | Current |
| 71335-0833-4 | 71335083304 | 60 TABLET in 1 BOTTLE (71335-0833-4) | 60 tablet | 2019-10-02 | 0000-00-00 | No | No | Current |
| 71335-0833-5 | 71335083305 | 500 TABLET in 1 BOTTLE (71335-0833-5) | 500 tablet | 2018-05-11 | 0000-00-00 | No | No | Current |
| 71335-0833-6 | 71335083306 | 10 TABLET in 1 BOTTLE (71335-0833-6) | 10 tablet | 2021-12-27 | 0000-00-00 | No | No | Current |
| 71335-0833-7 | 71335083307 | 100 TABLET in 1 BOTTLE (71335-0833-7) | 100 tablet | 2024-04-04 | | No | No | Historical |